Bioxyne to be renamed as BLS Pharmaceuticals to ‘reduce brand confusion’ by Adam Sheldon June 23, 2026June 25, 2026 Bioxyne shareholders have backed a proposal to rename the firm BLS Pharmaceuticals Limited, with more than […]
Bioxyne lifts FY26 guidance after margin growth in strong first half by Steve Jones February 26, 2026February 26, 2026
News in brief: MedReleaf expands product range; Bioxyne receives first psilocybin order; Greencare names medical lead by Steve Jones February 11, 2026June 8, 2026
Bioxyne enters Central American markets with pastille supply deal by Steve Jones December 12, 2025December 12, 2025
‘Not a revenue grab’: Curaleaf International CEO maps out Australian expansion plan by Adam Sheldon November 27, 2025December 2, 2025
